켄터키의 비만 임상 시험
비만 관련 연구 30개가 켄터키 내 여러 지역에서 참여자를 모집하고 있습니다.
켄터키의 도시
공식 연구 텍스트(영어)
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Monroe Biomedical Research, Louisville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 9. 업데이트됨 · NCT07351045Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- AMR Clinical - Lexington, Lexington
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 11. 6. 업데이트됨 · NCT07685808A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity
- Monroe Biomedical Research, Louisville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 5. 업데이트됨 · NCT07845500A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Equity Medical - Bowling Green, Bowling Green
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06857942Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)
- Norton Children's Endocrinology, Louisville
피험자 모집 중3상
6세 ~ 11세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07817875A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- AMR Clinical, Lexington
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07392190Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Monroe Biomedical Research - Louisville, Louisville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT07353931Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Health Partners, Louisville
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Health Partners, Louisville
피험자 모집 중3상
18세 ~ 70세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06937086A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Norton Children's Endocrinology, Louisville
피험자 모집 중3상
6세 ~ 17세 · 모든 성별 · 2026. 11. 4. 업데이트됨 · NCT06672549Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA)
- The Alliance for Multispecialty Research - Lexington, Lexington
피험자 모집 중1상
18세 ~ 70세 · 모든 성별 · 2026. 11. 2. 업데이트됨 · NCT07908316A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Owensboro
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 10. 30. 업데이트됨 · NCT07784725Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- The Research Group of Lexington LLC, Lexington
피험자 모집 중3상
18세 ~ 99세 · 모든 성별 · 2026. 10. 29. 업데이트됨 · NCT07037459Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- L-MARC Research Center /ID# 282008, Louisville
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 27. 업데이트됨 · NCT07752979MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease
- University of Kentucky, Lexington
피험자 모집 중
12세 ~ 17세 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07478653A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- Monroe Biomedical Research - Louisville, Louisville
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 8. 업데이트됨 · NCT07589608A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- Monroe Biomedical Research - Louisville, Louisville
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 10. 7. 업데이트됨 · NCT06143956Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Louisville Metabolic and Atherosclerosis Research Center, Louisville
피험자 모집 중3상
18세 ~ 99세 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT07684235Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- L-MARC Research Center, Louisville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07770841A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
- The Alliance for Multispecialty Research LLC AMR, Lexington
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 4. 업데이트됨 · NCT07745504The Effects of Mirabegron and Tadalafil on Glucose Tolerance in Prediabetics
- University of Kentucky, Lexington
피험자 모집 중4상건강한 지원자 환영
35세 ~ 65세 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT05051436A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
- The Research Group of Lexington LLC, Lexington
- UofL Health Care Outpatient, Louisville
- Research Integrity Global, LLC, Owensboro
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT07567001AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
- Monroe Biomedical Research, LLC, Louisville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 17. 업데이트됨 · NCT07509307Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Louisville
피험자 모집 중3상
18세 ~ 79세 · 모든 성별 · 2026. 8. 10. 업데이트됨 · NCT07654361Cannabis for Obesity Trial
- University of Kentucky, Lexington
피험자 모집 중2상건강한 지원자 환영
18세 ~ 65세 · 모든 성별 · 2026. 8. 7. 업데이트됨 · NCT06137365Mitigation of Cardiovascular Disease Risks in Children With Extreme Obesity
- University of Kentucky, Lexington
피험자 모집 중관찰 연구
12세 ~ 17세 · 모든 성별 · 2026. 7. 21. 업데이트됨 · NCT06967389A Phase 2A Clinical Trial to Assess the Safety and Tolerability of ERX1000 in Men and Women for the Treatment of Obesity.
- Monroe Biomedical Research, Louisville
피험자 모집 중2상
18세 ~ 60세 · 모든 성별 · 2026. 6. 22. 업데이트됨 · NCT07570758A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MBX 4291 in Adult Participants With Obesity
- MBX Biosciences Investigational Site, Lexington
피험자 모집 중1상
18세 ~ 65세 · 모든 성별 · 2026. 6. 9. 업데이트됨 · NCT071427072024 Tirzepatide-Bariatric Surgery
- University of Kentucky, Lexington
피험자 모집 중4상
18세 이상 · 모든 성별 · 2026. 5. 14. 업데이트됨 · NCT06721507Adrenergic Cholinergic Enteric Measures/Mapping
- University of Louisville, Louisville
피험자 모집 중관찰 연구
10세 ~ 80세 · 모든 성별 · 2025. 1. 10. 업데이트됨 · NCT04013282ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.